News Releases
Sep 15 2006
Peregrine's Anti-Phospholipid Technology Platform Broadened by Newly Validated Anti-Cancer Target
Sep 11 2006
Peregrine Pharmaceuticals Reports Financial Results for First Quarter FY 2007
Sep 11 2006
Peregrine to Initiate Bavituximab Combination Therapy Trial in India With Multiple Cancer Chemotherapy Regimens
Sep 6 2006
Peregrine Pharmaceuticals to Announce First Quarter FY 2007 Financial Results
Aug 16 2006
Peregrine's Final HCV Phase 1a Study Results Accepted for Oral Presentation at AASLD Annual Meeting
Jul 14 2006
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2006
Jul 10 2006
Peregrine Pharmaceuticals to Announce Year-End FY 2006 Financial Results
Jul 5 2006
Peregrine Pharmaceuticals to Join Russell 3000(R) Index
Jun 22 2006
Peregrine Pharmaceuticals to Present at Jefferies Life Sciences Conference
Jun 19 2006
Peregrine Pharmaceuticals Announces $13 Million Equity Financing